SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

A sharp XCN price spike and large candle are driving attention, with traders debating whether it is a pump-and-dump or a dip-buying opportunity; some note there is no clear news behind the move. Others link the coins moves to Bitcoins swings and the broader crypto market.

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

A reported take-private bid involving Irth Capital and Papa Johns largest U.S. franchisee is driving attention, with traders debating whether the board will pursue a sale or stick with its turnaround plan. Many criticize management amid weak sales and the dividend suspension, while others remain skeptical that a deal will materialize.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Positive Phase 3 results for Amgens IMDELLTRA with AstraZenecas IMFINZI in first-line extensive-stage small-cell lung cancer are driving attention, with the combination reducing the risk of death by 58%. Traders see potential for a new oncology growth driver, while some emphasize Repatha as the more established contributor to Amgens business.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Updated NEST Phase 2 results for Agenuss BOT+BAL combination in neoadjuvant colorectal cancer are drawing attention, with supporters pointing to strong tumor responses and no observed recurrences during follow-up. Traders debate whether the small, nonrandomized studies will translate into Phase 3 and regulatory success, while execution and dilution concerns remain.

Sony Group Corp. engages in the development, design, manufacture, and sale of electronic equipment, instruments, devices, game consoles, and software for consumers, professionals and industrial markets. It operates through the following segments: Game and Network Services, Music, Pictures, Entertainment Technology & Services, Imaging and Sensing Solutions, Financial Services, and Others. The Game and Network Services segment deals with gaming machines, software and network services. The Music segment produces and publishes music and provides image media platforms. The Pictures segment handles film production, television program creation, and media networks. The Home Entertainment and Sound segment offers LCD televisions, home audio, Blu-ray Disc players and recorders, and memory-based portable audio devices. The Imaging and Sensing Solutions segment includes the image sensors business. The Financial Services segment manages the life insurance and non-life insurance operations and banking business. The Others segment consists of various operating activities, including the disc manufacturing and recording media businesses. The company was founded by Akio Morita and Masaru Ibuka on May 7, 1946 and is headquartered in Tokyo, Japan.

Sony Group Corporation - ADR

Sony Group Corporation

Sonys plan to stop producing physical PlayStation game discs in 2028 is driving debate: critics warn it could alienate players and push them toward PC gaming, while supporters argue digital distribution could cut costs and improve margins. Traders are also weighing this consumer backlash against Sonys broader gaming and technology prospects.

iShares Trust - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

Softwares renewed relative strength and rotation against semiconductors are drawing attention, with traders debating whether AI will boost established software businesses or disrupt them. Bulls see a broader SaaS recovery, while skeptics view the sectors leadership as volatile and potentially temporary.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco is drawing attention as a defensive consumer-staples name during rotation away from AI and technology stocks, with traders also watching its push through a major psychological price level. The bullish momentum is countered by concerns that its valuation is stretched and that recent gains may pull back.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

CCXI is drawing attention as the SPAC merger vehicle for Agility Robotics, giving traders exposure to humanoid robots and prompting comparisons with Unitrees IPO and discussion of reported U.S. restrictions on Chinese-made robots. Bullish traders point to Agilitys customer deployments and major backers, while skeptics cite its losses, valuation, dilution risk, and the track record of SPACs.

Wormhole is a cross-chain messaging protocol that enables secure transfers of data or tokens across different blockchain networks. It supports a variety of applications, including DeFi, NFTs, and governance, by allowing data to be moved between blockchains efficiently and securely. Wormhole employs multiple verification methods to ensure the integrity and validity of the data transmitted through its network.

Wormhole

Traders are highlighting Wormholes reported integration with Ripple and the XRP Ledger as a potential boost to cross-chain adoption, alongside its role in tokenization and institutional projects. Bullish calls for a rebound and buying activity are countered by frustration over weak price action and concerns about token unlocks and selling pressure.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTechs oncology pipeline is driving discussion, with traders weighing encouraging trial updatesincluding BNT323s Phase 2 endometrial-cancer results and pumitamig dataagainst earlier clinical setbacks. Sentiment is divided: some see the large cash reserve and late-stage pipeline as undervalued, while others remain concerned about execution and the founders departure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Elevance Health, Inc. (ELV) Outperforming Other Medical Stocks This Year?

Here is how Elevance Health (ELV) and Astellas Pharma Inc. (ALPMY) have performed compared to their sector so far this year.

Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers

Trump's MFN push expands to nine mid-sized drugmakers, bringing 26 companies under agreements covering 89% of the branded drug market.

New Strong Sell Stocks for August 19th

ASEKY, ALPMY and ATS have been added to the Zacks Rank #5 (Strong Sell) List on August 19, 2026.

New Strong Sell Stocks for August 6th

COIN, ALPMY and MUX have been added to the Zacks Rank #5 (Strong Sell) List on August 6th, 2026.

Are Medical Stocks Lagging  Astellas Pharma (ALPMY) This Year?

Here is how Astellas Pharma Inc. (ALPMY) and Aurinia Pharmaceuticals (AUPH) have performed compared to their sector so far this year.

Is Astellas Pharma (ALPMY) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Astellas Pharma (ALPMY) a Great Value Stock Right Now?

Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year?

Is OCGN Stock Worth the Risk Ahead of 2026-27 Eye Gene Therapy Data?

Ocugen faces cash burn and dilution risks, but upcoming eye gene therapy data and planned filings through 2027 could shape its next phase.

MRK Stock Gains After CHMP Backs Keytruda Combo for Bladder Cancer

Merck jumps after CHMP backs Keytruda plus Padcev for certain bladder cancer patients, a combo with the potential to expand treatment options.

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

Astellas Pharma Inc. - ADR

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$15.95
Prev Close	$15.77
Open	$15.90
Dividend Yield	2.38%
50-Day Moving Average	$14.85
Beta	0.29
Avg. Volume	103,096.00
PE Ratio	12.13

52-Week High	$17.35
52-Week Low	$10.05
Market Capitalization	$28.6B
EPS (Annual)	$1.08
Price to Book	2.39
Revenue Per Employee	$1.01M

Feed

News

Sentiment

Earnings

Fundamentals

Info

ALPMY Fundamentals